Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients (Q21144330)
Jump to navigation
Jump to search
scientific article
- Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients |
scientific article |
|
Statements
Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients (English)
0 references
Joep Killestein
Joep
Killestein
Lisa G M van Baarsen
Saskia Vosslamber
Marianne Tijssen
Josefien M C Baggen
Laura F van der Voort
Tineke C T M van der Pouw Kraan
Cornelis L Verweij
2008
0 references
3
0 references
4
0 references
e1927
0 references
2 April 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference